Your browser doesn't support javascript.
loading
Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder.
Lobello, Kasia W; Preskorn, Sheldon H; Guico-Pabia, Christine J; Jiang, Qin; Paul, Jeffrey; Nichols, Alice I; Patroneva, Albena; Ninan, Philip T.
Affiliation
  • Lobello KW; Wyeth Research, Collegeville, Pennsylvania 19426, USA. kasia.lobello@pfizer.com
J Clin Psychiatry ; 71(11): 1482-7, 2010 Nov.
Article in En | MEDLINE | ID: mdl-20441720
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bipolar Disorder / Selective Serotonin Reuptake Inhibitors / Cytochrome P-450 CYP2D6 / Cyclohexanols Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Psychiatry Year: 2010 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bipolar Disorder / Selective Serotonin Reuptake Inhibitors / Cytochrome P-450 CYP2D6 / Cyclohexanols Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Psychiatry Year: 2010 Document type: Article Affiliation country: United States Country of publication: United States